Generating knowledge and providing greater understanding so that - - PDF document

generating knowledge and providing greater understanding
SMART_READER_LITE
LIVE PREVIEW

Generating knowledge and providing greater understanding so that - - PDF document

Attendees and Presentation Schedule 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 25-28, 2016 Dublin, Ireland Generating knowledge and providing greater understanding so that you can make


slide-1
SLIDE 1

Attendees and Presentation Schedule

32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 25-28, 2016 Dublin, Ireland

Generating knowledge and providing greater understanding so that you can make better decisions.

Let us help you reduce the uncertainty of risks to patients by investigating disease epidemiology, drug-outcome associations, and product usage in routine clinical practice and by evaluating the effectiveness of your risk minimization strategies.

rtihs.org/ICPEDublin

slide-2
SLIDE 2

Wednesday, August 24 | ICPE Pre-Conference Educational Session Contributions

8:30am-12:30pm Medical Device Epidemiology. C. Anderson-Smits, J. Jalbert, K. Etter, M. Ritchey, C. Holy, K. Davis, M. Steinbuch [Wicklow Meeting Room 4] 8:30am-12:30pm Introduction to the Evaluation of Therapeutic Risk Management Programs. G. Dal Pan, A. Spooner, L. Wise, M. Smith, E. Morrato, J. Jones, A. Gilsenan [Lifgey Meeting Room 3] 2:00-6:00pm Benefjt-Risk Assessment and Patient Preferences: Methodology and Tools for the Practitioner. T. Hammad, J. Juhaeri, A. B. Hauber, R. Noel [Lifgey Meeting Room 3]

Thursday, August 25 | ICPE Pre-Conference Educational Session Contributions

8:30am-12:30pm Modern Pregnancy Pharmacoepidemiology: Methodological Challenges in Exposure Measurement and Implications for Study Design and Analysis.

  • B. Bateman, K. Huybrechts, H. Kieler, A. Margulis [Wicklow Meeting Room 5]

2:00-6:00pm Advanced Pharmacoepidemiology Methods. S. Cadarette, R. Glynn, K. J. Rothman, H. Whitaker [Lifgey Hall 1]

Friday, August 26 | ICPE Scientifjc Session Contributions

11:00-11:15am Evaluating Patient Knowledge of Risks and Safe Use of Xarelto (Rivaroxaban) [9]. L. J. Zografos, K. Suzart, A. Horvat-Broecker, M. Soriano-Gabarro,

  • D. L. Wolin, B. Calingaert, E. K. Davenport, K. A. Hollis, E. Andrews [Contributed Paper Session - BRACE Yourself]

3:30-5:00pm Real World Efgectiveness: How Efgective is It? S. Garner, E. Andrews, T. van Staa [Plenary] 5:00-6:30pm Patient Engagement in Observational Pharmacoepidemiology Research: Where Are We, Where Do We Need to Be, and What Are the Steps for Getting There? [74] N. Heath, W. Camelo Castillo, T. Majid, E. Yucel, K. Yang, I. Petersen, N. Santanello, S. DosReis, S. West [Symposium] Lifgey B 5:00-6:30pm Does Randomization Work? Selection Bias in Pragmatic Randomized Clinical Trials and Unblinded Observational Studies: A CER SIG Endorsed Symposium [78]. C. Girman, K. Davis, L. Smeeth, S. Garner, M. Ritchey, C. de Vries, A. Roddam [Symposium] Lifgey Hall 1 5:00-6:30pm Exploring Innovative Methods to Conduct Validation Using United States Medicare Administrative Claims Data [79]. E. Andrews, T. Stürmer, L. McGrath,

  • M. Jonsson Funk, J. Lund, C. Johannes, A. Gilsenan [Symposium] Lifgey Meeting Room 2

8:00am-6:00pm Evaluation of Free-Text Comments to Validate Common Cancer Diagnoses in the UK CPRD [91]. J. Fortuny, J. Kaye, C. Bui, A. Gilsenan, J. Bartsch,

  • E. Plana, L. McQuay, B. Calingaert, A. Margulis, W. J. Atsma, K. Appenteng, B. Franks, S. de Vogel, M. D’Silva, S. Perez-Gutthann, A. Arana

[Spotlight Session 12:15-1:15 pm - Databases Poster] 8:00am-6:00pm An Algorithm to Identify Duplicate Patients When Pooling Aggregate Data from Two Primary Care Databases in the United Kingdom [93]. E. Plana,

  • L. McGrath, J. Fortuny, A. Ruigomez, O. Fernandez-Cantero, L. Garcia-Rodriguez, A. Gilsenan, E. Andrews, C. Rebordosa, R. Ziemiecki

[Spotlight Session 12:15-1:15pm - Databases Poster] 8:00am-6:00pm Improving Short-Term Mortality Prediction Using Timing of Acute Comorbidities During Lookback [235]. H. Zhang, L. McGrath, A. Ellis, R. Wyss, J. Lund,

  • T. Stürmer [Confounding/Bias Poster]

8:00am-6:00pm Probabilistic Bias Analysis for Unmeasured Confounders in a Study of Users of Topical Tacrolimus, Pimecrolimus and Corticosteroids (JOELLE Study) [238]. J. Castellsague, B. Calingaert, K. Rothman, L. Gutierrez, M. van Herk-Sukel, J. Kuiper, A. Pottegård, J.Hallas, I. Berglind, A. Sundstrom, D. Dedman,

  • A. Gallagher, J. Kaye, C. Pardo, S. Perez-Gutthann [Confounding/Bias Poster]

8:00am-6:00pm Reporting of the Trimmed Population in Propensity Score Analyses [246]. D. Odom, X. Zhou, S. Thomas [Confounding/Bias Poster] 8:00am-6:00pm Complementary Observational Studies Assessing the Incidence of a Rare Cancer Outcome by Linking State Cancer Registry Data to Large Pharmacy Claims Databases in the United States [254]. N. Kellier-Steele, A. Gilsenan, K. Midkifg, D. Harris, E. Andrews [Data Linkage Poster] 8:00am-6:00pm Characterization of New Users of Cilostazol in the United Kingdom, Spain, Sweden, and Germany [348]. J. Castellsague, B. Calingaert, B. Poblador-Plou,

  • M. Giner-Soriano, M. Linder, O. Scholle, C. Varas-Lorenzo, A. Arana, C. Bui, A. Prados-Torres, F. Gonzalez-Rubio, A. Roso-Llorach, A. Citarella, E. Garbe,
  • T. Blenk, S. Perez-Gutthann [Use of Medicines - Hematological and Cardiovascular Poster]

8:00am-6:00pm Drug Utilization Study: Evaluation of the Use of Nepafenac in The Netherlands and Denmark [387]. A. Margulis, E. Houben, M. Olesen, J. Hallas,

  • J. Overbeek, A. Pottegård, W. Ye, D. Villegas, S. Perez-Gutthann, A. Arana [Use of Medicines - Other Poster]

Saturday, August 27 | ICPE Scientifjc Session Contributions

8:30-8:45am Use of Non-Insulin Blood Glucose Lowering Drugs and the Risk of Acute Pancreatitis [422]. G. Masclee, I. Leal, L. Scotti, G. De Berardis, I. Bezemer, M. Gil,

  • A. McGrogan, N. Schmedt, J. D. Seeger, G. Trifjro, S. Pecchioli, M. Pladevall-Vila, M. M. Smits, P. Rijnbeek, M. Sturkenboom, S. A. Romio

[Contributed Paper Session - A Sticky Subject: Diabetes Safety] 9:15-9:30am Validation of Cardiovascular Events and Covariates in CPRD GOLD Using Questionnaires to General Practitioners (GPs) [437]. A. Margulis,

  • C. Varas-Lorenzo, C. Bui, L. McQuay, R. Ziemiecki, M. Reynolds, C. Rebordosa, M. Pladevall-Vila, J. Fortuny, E. Rivero-Ferrer, E. Plana, W. J. Atsma,
  • K. Appenteng, B. Franks, S. de Vogel, M. D’Silva, S. Perez-Gutthann, A. Arana [Contributed Paper Session - Identifjcation and Validation of Outcomes]

2:00-2:15pm Exposure Misclassifjcation and Inverse Probability Weighting: A Plasmode Simulation [472]. M. M. Conover, K. J. Rothman, T. Stürmer, C. Poole,

  • M. Jonsson Funk [Contributed Paper Session - A Methods Coddle]

4:00-5:30pm The Epidemiological Approach to Rare Disease Research: Challenges and Opportunities [479]. M. Ritchey, J. Jalbert, A. Gilsenan, T. Lystig, M. Peng,

  • T. Kou, W. Blumentals [Symposium] Lifgey Hall 2

The power of knowledge. The value of understanding.

slide-3
SLIDE 3

8:00am-6:00pm Evaluating Physician Knowledge of Risks and Safe Use of Xarelto (Rivaroxaban) [493]. L. J. Zografos, K. Suzart, A. Horvat-Broecker, M. Soriano-Gabarro,

  • D. L. Wolin, B. Calingaert, E. K. Davenport, K. A. Hollis, E. Andrews [Spotlight Session 11:45am-12:45pm - BRACE Poster]

8:00am-6:00pm Preconception Use of Pain Relieving Medication and Time to Pregnancy: A Prospective Study [509]. K. A. McInerney, E. E. Hatch, A. K. Wesselink,

  • K. J. Rothman, E. M. Mikkelsen, L. A. Wise [Spotlight Session 11:45am-12:45pm - Meds in Pregnancy Poster]

8:00am-6:00pm Evaluation of Risk Minimisation Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg [529]. K. H. Davis, A. Asiimwe, L. J. Zografos,

  • D. J. McSorley, E. Andrews [BRACE Poster]

8:00am-6:00pm Use of Cognitive Testing to Optimize Questionnaire Wording and Mode of Administration in the Evaluation of Risk Minimization Activities [547].

  • L. J. Zografos, E. Andrews, D. Whalley, P. Petraro, Z. Vassilev [BRACE Poster]

8:00am-6:00pm Pregnancy Studies Assessing Drug Exposure in Populations With Multiple Sclerosis [573]. W. Krueger, M. Anthony, B. Monz, C. Saltus, C. Hirst,

  • A. Margulis, E. Andrews [Pregnancy Poster]

8:00am-6:00pm The EpiChron Cohort Proven Useful for Pharmacoepidemiological Studies [684]. A. Prados-Torres, B. Poblador-Plou, F. González-Rubio, A. Gimeno Miguel,

  • J. Castellsague, S. Perez-Gutthann, A. Arana [Potpourri Poster]

8:00am-6:00pm Description of 2014-2015 ICPE Abstract Submissions [686]. M. Ritchey [Potpourri Poster] 8:00am-6:00pm Risk of Hemorrhagic Stroke Associated with Non-Insulin Blood Glucose Lowering Drugs. Results from the SAFEGUARD Project [737]. M. Gil, S. Romio,

  • L. Scotti, I. Leal, G. Masclee, N. Schmedt, C. Varas-Lorenzo, M. Pladevall-Vila, M. Smits, I. Bezemer, J. Seeger, G. De Beradis, S. Pecchioli, G. Trifjro,
  • A. McGrogan, P. Rijnbeek, M. Sturkenboom [Pharmacovigilance - Alimentary & Metabolic Poster]

8:00am-6:00pm Study Update for a Postmarketing Case Series Study of Adult Osteosarcoma and Teriparatide in the US [752]. K. Midkifg, D. Harris, A. Gilsenan,

  • D. McSorley, N. Kellier-Steele, D. Masica, E. Andrews [Pharmacovigilance - Cancer Poster]

Sunday, August 28 | ICPE Scientifjc Session Contributions

9:30-9:45am Risk of Acute Myocardial Infarction Associated with Non-Insulin Blood Glucose Lowering Drugs. Results from the SAFEGUARD Project [801]. I. Leal,

  • G. Muscle, L. Scotti, G. DeBerardis, I. Bezemer, M. Gil, E. Martin, A. McGregor, N. Schmedt, J. D. Seeger, G. Trifjro, S. Pecchioli, C. Varas-Lorenzo,
  • M. M. Smits, P. Rijnbeek, M. Sturkenboom, S. Romio [Contributed Paper Session - My Achy Breaky Heart: Diabetes & CVD]

1:30-3:00pm Transitioning to ICD-10: International Lessons Learned and Strategies for Moving Forward [830]. L. M. Lix, M. Pladevall-Vila, S. Toh, D. D. Dore [Symposium] Wicklow Hall 2 4:00-4:15pm Incidence of Cardiovascular Events in New Users of Overactive Bladder Medications in Denmark [848]. J. Hallas, A. Margulis, A. Pottegård, N. Kristiansen,

  • C. Bui, W. Krueger, W. J. Atsma, K. Appenteng, B. Franks, S. de Vogel, M. D’Silva, S. Perez-Gutthann, A. Arana [Contributed Paper Session - CV Adverse

Events: Afgairs of the Heart] 4:15-4:30pm Cardiovascular Risk in Users of Antimuscarinic Drugs for Overactive Bladder: A Cohort Study in the Swedish National Registers [849]. M. Linder,

  • A. Margulis, I. Anveden-Berglind, S. Bahmanyar, C. Bui, W. J. Atsma, K. Appenteng, B. Franks, S. de Vogel, M. D’Silva, S. Perez-Gutthann, A. Arana

[Contributed Paper Session - CV Adverse Events: Afgairs of the Heart] 4:00-4:15pm Risk of Lymphoma in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids (JOELLE study) [854]. J. Castellsague, J. Kuiper, A. Pottegård,

  • I. Anveden-Berglind, D. Dedman, L. Gutierrez, B. Calingaert, M. van Herk-Sukel, J. Hallas, A. Sundstrom, A. Gallagher, J. Kaye, C. Pardo, K. Rothman,
  • S. Perez-Gutthann [Contributed Paper Session - Adverse Outcomes of Glucocorticoid and Immunomodulator Use]

8:00am-1:45pm Uptake and Predictors of TDaP Immunization During Pregnancy in Privately-Insured US Women, 2010-2013 [899]. A. M. Butler, J. Bradley Layton, D. Li,

  • M. G. Hudgens, K. A. Boggess, L. McGrath, S. Becker-Dreps [Vaccines Poster]

8:00am-1:45pm Risk of Skin Cancer in Users of Topical Tacrolimus, Pimecrolimus, and Corticosteroids. Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE) Study [908]. J. Castellsague, M. van Herk-Sukel, J. Hallas, A. Sundstrom, A. Gallagher, L. Gutierrez, B. Calingaert, J. Kuiper,

  • A. Pottegård, I. Berglind, D. Dedman, J. Kaye, C. Pardo, K. Rothman, S. Perez-Gutthann [Safety & Efgectiveness - Cancer Poster]

8:00am-1:45pm Elevated Bladder and Prostate Cancer Rates Following Initiation of OAB Medication: Findings from a Danish Registry [918]. J. Hallas, A. Margulis,

  • A. Pottegård, J. Kaye, N. Kristiansen, C. Bui, W. J. Atsma, K. Appenteng, B. Franks, S. de Vogel, M. D’Silva, S. Perez-Gutthann, A. Arana

[Safety & Efgectiveness - GU & Hormones Poster] 8:00am-1:45pm Cancer Risk in Users of Antimuscarinic Drugs for Overactive Bladder: A Cohort Study in the Swedish National Registers [919]. M. Linder, A. Margulis,

  • I. Anveden-Berglind, S. Bahmanyar, C. Bui, W. J. Atsma, K. Appenteng, B. Franks, S. de Vogel, M. D’Silva, S. Perez-Gutthann, A. Arana

[Safety & Efgectiveness - GU & Hormones Poster] 8:00am-1:45pm Do Individual Antimuscarinic Drugs to Treat Overactive Bladder Have Difgerent Cardiovascular Risks? A UK CPRD Cohort Study [920]. A. Arana,

  • C. Varas-Lorenzo, L. McQuay, R. Ziemiecki, C. Bui, A. Gilsenan, K. Rothman, W. J. Atsma, K. Appenteng, B. Franks, S. de Vogel, M. D’Silva, A. Margulis,
  • S. Perez-Gutthann [Safety & Efgectiveness - GU & Hormones Poster]

8:00am-1:45pm Utilization of Tacrolimus and Pimecrolimus in Europe: Results from the Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE) Study [1087]. J. Kuiper, M. van Herk-Sukel, J. Castellsague, A. Pottegård, I. Berglind, D. Dedman, L. Gutierrez, B. Calingaert, J. Hallas, A. Sundstrom,

  • A. Gallagher, J. Kaye, C. Pardo, K. Rothman, S. Perez-Gutthann [DUR - Trends Poster]

8:00am-1:45pm Characteristics of Patients Prescribed Prucalopride Versus an Active Comparator in England, Wales, and Northern Ireland [1093]. L. McGrath,

  • A. Ruigomez, E. Plana, J. Fortuny, L. Garcia-Rodriguez, C. Rebordosa, C. Varas-Lorenzo, R. Ziemiecki, A. Gilsenan, E. Andrews

[DUR - Trends in Alimentary and Metabolic Poster] 8:00am-1:45pm Patterns of Use of Antimuscarinic Drugs to Treat Overactive Bladder in Denmark, Sweden and the United Kingdom [1126]. A. Margulis, M. Linder,

  • A. Arana, A. Pottegård, I. Anveden-Berglind, C. Bui, N. Kristiansen, S. Bahmanyar, L. McQuay, W. J. Atsma, K. Appenteng, B. Franks, S. de Vogel, M. D’Silva,
  • S. Perez-Gutthann, J. Hallas [DUR - Trends in GU and Hormones Poster]

8:00am-1:45pm Characteristics of New Users of Aclidinium Bromide in the United Kingdom [1166]. C. Rebordosa, C. Varas-Lorenzo, J. Castellsague, E. Plana, C. Bui,

  • J. Aguado, E. Garcia Gil, S. Perez-Gutthann [DUR - Trends in Respiratory Poster]
slide-4
SLIDE 4

Meet us at ICPE

Elizabeth Andrews

VP, Pharmacoepidemiology & Risk Management eandrews@rti.org

Jaume Aguado

Senior Statistician jaguado@rti.org

Kim Davis

Director, Surveys and Observational Studies kimdavis@rti.org

Jordi Castellsague

Senior Director, Epidemiology castellsague@rti.org

Alicia Gilsenan

Senior Director, Epidemiology agilsenan@rti.org

Joan Fortuny

Senior Research Epidemiologist jfortuny@rti.org

Whitney Krueger

Research Epidemiologist wkrueger@rti.org

Kelly Hollis

Global Head, Surveys and Observational Studies khollis@rti.org

Leah McGrath

Research Epidemiologist lmcgrath@rti.org

Andrea Margulis

Director, Epidemiology amargulis@rti.org

Kirk Midkifg

Director, Epidemiology kmidkifg@rti.org

Brett Hauber

Senior Economist & VP, Health Preference Assessment abhauber@rti.org

Kenneth Rothman

Distinguished Fellow & VP, Epidemiology Research krothman@rti.org

Ryan Ziemiecki

Senior Statistician rziemiecki@rti.org

Sue West

RTI Fellow & Senior Scientist swest@rti.org

Laurie Zografos

Senior Director, Surveys and Observational Studies zografos@rti.org

Mary Beth Ritchey

Principal Epidemiologist for Medical Devices mritchey@rti.org

Susana Perez-Gutthann

Vice President, Global Head, Epidemiology sperez@rti.org

Alejandro Arana Navarro

Director, Epidemiology aarana@rti.org

Estel Plana

Senior Statistician eplana@rti.org

Manel Pladevall-Vila

Director, Epidemiology mpladevall@rti.org

Cristina Rebordosa

Senior Research Epidemiologist crebordosa@rti.org